Pérez EMM, García RME, Armas MK, Álvarez MI, Oliva DJA, Pérez EE

Language: Spanish
References: 10
Page: 258-263
PDF size: 346.57 Kb.

ABSTRACT

Background: adenocarcinoma is the most frequently type of lung cancer in women and is non-smoker people. Adenocarcinoma developes slower, but tends to metastasize sooner and spreads widely. Only a few number of patients reachs cure.
Objective: to present a clinical case of adenocarcinoma carries with big pulmonary cells.
Case clinical: a 58 years old male smoker patient is presented, paraneoplasics manifestations preceded that of the tumor properly, during more than seven months of valuation.
Conclusions: this case is presented don account of few curability refered in lung cancer, with favorable evolution and more than 2, 5 years of survivance after surgery, oncologic treatment and immunotherapy. A review of concerned literature in relation with clinical aspects, diagnosis and therapeutics about this tumor, lees frequently in male was presented.

REFERENCES

1. Roca Goderich R. Temas de Medicina Interna. 4ta ed. La Habana: Editorial Ciencias Médicas; 2002.

2. Campos Parra AD, Cruz Risco G, Arrieta O. Personalización del tratamiento del cáncer de pulmón de células no pequeñas. Rev Invest Clin [Internet]. Jul- Ago 2012 [citado 28 Ene 2016];64(4):[aprox. 8 p.]. Disponible en: http://www.medigraphic.com/pdfs/revinvcli/nn-2012/nn124h.pdf

3. Lima Guerra A, Gassiot Nuño C, Ramos Que-vedo A, Rodríguez Vázquez JC, Cabanes Varona L, Morales Sánchez L, et al. Conducta diagnósti-ca y pronóstico en pacientes con carcinoma pul-monar de células no pequeñas en estadios qui-rúrgicos. Rev Cubana Med [Internet]. 2012 [citado 28 Ene 2016];51(1):[aprox. 12 p.]. Dis-ponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232012000100003

4. Husain AN. Pulmón. En: Kumar V, Abbas AK, Fausto N, Aster JC, editores. Robbins y Cotran. Patología estructural y funcional. 8 ed. Barcelo-na: Elsevier; 2010. p. 677- 738.

5. Stricker TP, Kumar V. Neoplasias. En: Kumar V, Abbas AK, Fausto N, Aster JC, editores. Rob-bins y Cotran. Patología estructural y funcional. 8 ed. Barcelona: Elsevier; 2010. p. 259-330.

6. Vázquez Sequeiros E, González Panizo Tamar-go F, Barturen A, Calderón A, Esteban JM, Fer-nández G. The role of endoscopic ultrasound guided fine needle aspiration (EUS-FNA) in non-small cell lung cancer (NSCLC) patients: SEED-SEPD-AEG Joint Guideline. Rev Esp Enferm Dig [Internet]. 2013 [citado 28 Ene 2016];105(4):[aprox. 10 p.]. Disponible en: http://dx.doi.org/10.4321/S1130-01082013000400006

7. Parkl L, Lyons G, Lescano M, Di Prieto E, Chi-mondeguey D. Análisis de N2 insospechado de cáncer de pulmón de células no pequeñas esta-dio clínico 1 a: impacto de la estadificación ac-tual y localización del tumor. Rev Argent Cir [Internet]. 2013 [citado 28 Ene 2016];105(1):[aprox. 12 p.]. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S2250-639X2013000300001

8. Sharples LD, Jackson C, Wheaton E, Griffith G, Annema JT, Dooms C, et al. Clinical effective-ness and cost- effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: Results from de ASTER randomized controlled trial. Health Technol Assess. 2012;16:1-75.

9. Pérez L, Estévez D, Gastón Y, Macías A, Viada CE. Seguridad del Racotumomab en el trata-miento de pacientes con cáncer de pulmón de células no pequeñas. Vaccimonitor [Internet]. Ene-Abr 2013 [citado 28 Ene 2016];22(1):[aprox. 14 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1025-028X2013000100003&script=sci_arttext

10. Saurez Martínez G, Bencomo Yanes A. Nimo-tuzumab, effective immunotherapy for the treat-ment of malignant epithelial tumor. Biotecnol Apl [Internet]. 2014 [citado 2016 Ene 28];31(2):[about 12 p.]. Available from: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522014000200007&lng=es&nrm=iso